Recent Media Coverage

A woman who lost her legs after cancer treatment wants to "come home" - but faces being moved 35 miles away.

The Blue Cross Blue Shield Association and others say they have agreed to invest in a nonprofit’s effort to develop and sell cheaper drugs.

Americans are having to choose between paying their mortgage and paying for insulin.

How Germany sets drug prices and identifying lessons for the United States.

To ensure the ongoing affordability of generic medications for Americans, BCBS is committing $55 million to establish a partnership with Civica Rx to reduce costs of generics for consumers.

No bill was too small to get PhRMA’s attention.

The intergovernmental regional initiatives of collaboration around access to medicines policy are here to stay.

THE UK Government has sought to reassure MSPs that medicine prices will not be affected as part of any future UK-US trade deal after Brexit.

State and federal spending on prescription drugs is dramatically outpacing inflation, even after accounting for rebates, according to a new analysis of federal data.

UK's NICE has rejected a number of drugs from coverage recently based on cost-effectiveness criteria.

State health leaders trying to reduce the number of people dying from overdoses.

Insulin is not an optional medication for diabetics. Despite little change in production costs, the price of insulin has continued to rise.